Eppinix XL (ropinirole) has been launched for the treatment of Parkinson’s disease as initial monotherapy or in combination with levodopa over the course of the disease. The range includes 3mg and 6mg prolonged-release tablets in addition to the 2mg, 4mg and 8mg strengths of ropinirole already available.
The most up-to-date drug information at your fingertips.
- Get the prescribing support you need.
- Register today for full access to the MIMS database, plus tables and guideline summaries, new and deleted products and consultation tools.
Potential sensitising agents in eye drops and ointments.
Available formulations of anti-anginal drugs.
Delaying or withholding antibiotics for symptoms of...
Compatible test strips for blood glucose meters.